Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 150, pseudogene (RNU1-150P) is a pseudogene, meaning it is a DNA sequence similar to a functional gene but regarded as generally nonfunctional due to mutations or the lack of required regulatory elements[1][3]. U1 small nuclear RNAs are core components of the spliceosome, essential for pre-mRNA splicing in eukaryotic cells, and are usually encoded by multi-gene families with numerous pseudogenes distributed throughout the genome[3]. While traditional pseudogenes were assumed nonfunctional, some “variant” U1 small nuclear RNA pseudogenes are now known to be transcribed and have regulatory functions at the RNA level, affecting pre-mRNA processing and gene expression. However, there is no direct evidence that the RNU1-150P pseudogene itself is transcribed or has a specific biological or disease role. It is not considered a classical therapeutic target, receptor, enzyme, or druggable entity. Notes and context: - Pseudogenes may have regulatory roles by acting as decoys for microRNAs or via antisense transcripts that can regulate their protein-coding ancestors[2][4]. Yet, this function is only established for a subset of pseudogenes and not specifically for RNU1-150P. - Variant U1 snRNA pseudogenes (sometimes called vU1) are a subclass of U1 snRNA pseudogenes shown to be transcribed in some contexts, but the functional significance is mostly studied in aggregate or for selected variants[3][5]. - No known drugs, biomarkers, mechanisms of action, or safety concerns are associated with RNU1-150P. Summary: RNU1-150P is a non-coding RNA pseudogene for U1 small nuclear RNA, not known to be a drug or therapeutic target, with no established biological or disease function specific to itself, but similar pseudogenes can sometimes play regulatory roles in gene expression[1][3][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 150, pseudogene (RNU1-150P).